Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11590138 Topical treatment of vitiligo by a jak inhibitor

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Infobox
Patent Citations
‌
US Patent 11219624 Topical formulation for a JAK inhibitor
0
Edits on 4 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2023
Edits on 2 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
Edits on 25 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Mar, 2023
Edits on 1 Mar, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 1 Mar, 2023
Edits made to:
Infobox (+15 properties)
Article (+129 characters)
‌

 US Patent 11590138 Topical treatment of vitiligo by a jak inhibitor

Article

The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Incyte
Incyte
0
Current Assignee
Incyte
Incyte
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
115901380
Date of Patent
February 28, 2023
0
Patent Application Number
178608840
Date Filed
July 8, 2022
0
Patent Citations
‌
US Patent 11219624 Topical formulation for a JAK inhibitor
0
‌
US Patent 10610530 Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
0
‌
US Patent 10639310 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
0
‌
US Patent 10758543 Topical formulation for a JAK inhibitor
0
‌
US Patent 10869870 Topical formulation for a JAK inhibitor
0
Patent Primary Examiner
‌
Paul V Ward
0
CPC Code
‌
A61K 31/519
0

Find more entities like US Patent 11590138 Topical treatment of vitiligo by a jak inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.